Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–a systematic review

SC Clement, RP Peeters, CM Ronckers, TP Links… - Cancer treatment …, 2015 - Elsevier
Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …
被引用次数：172 相关文章

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–A systematic review

SC Clement, RP Peeters… - Cancer …, 2015 - cancertreatmentreviews.com
Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …

[引用][C] Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–A systematic review

SC Clement, RP Peeters, CM Ronckers… - Cancer Treatment …, 2015 - cir.nii.ac.jp
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid
carcinoma – A systematic review | CiNii Research CiNii 国立情報学研究所 学術情報 …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–A systematic review

SC Clement, RP Peeters, CM Ronckers… - Cancer Treatment …, 2015 - infona.pl
Treatment of differentiated thyroid carcinoma (DTC) often involves administration of
radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC has favorable …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review

SC Clement, RP Peeters… - Cancer treatment …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma-A systematic review

SC Clement, RP Peeters, CM Ronckers… - CANCER …, 2015 - research.rug.nl
Background: Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma-A systematic review

SC Clement, R Peeters, C Ronckers, T Links… - Cancer Treatment …, 2015 - repub.eur.nl
Background: Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review

SC Clement, LCM Kremer, BLF van Eck-Smit… - Cancer Treatment …, 2015 - hero.epa.gov
Abstract Treatment of differentiated thyroid carcinoma (DTC) often involves administration of
radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC has favorable …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review

SC Clement, RP Peeters… - Cancer …, 2015 - researchinformation.amsterdamumc …
Abstract Treatment of differentiated thyroid carcinoma (DTC) often involves administration of
radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC has favorable …

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review.

SC Clement, RP Peeters, CM Ronckers… - Cancer Treatment …, 2015 - europepmc.org
Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …